CRMD CorMedix Inc.
Nasdaq · SEC CIK 1410098 · EDGAR
- Bought, last 12 months
- $275.5K 1 purchases by 1 insiders
- Sold, last 12 months
- $2.64M 8 sales by 4 insiders
- Filings on record
- 125 since 2021-11-03, latest 2026-09-18 21:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dillione Janet | Dir | — | $1.55M |
| Lefkowitz Steven W | Dir | — | $475.2K |
| Todisco Joseph | CEO, Dir | — | $360.0K |
| Kaplan Myron | Dir | $275.5K | — |
| DUNTON ALAN W | Dir | — | $260.0K |
| Seckler Michael David | Chief Commercial Off | — | — |
| Zelnick Kaufman Beth | CLO | — | — |
| Duncan Gregory Scott | Dir | — | — |
| Blum Susan | CFO | — | — |
| Hurlburt Elizabeth | COO | — | — |
Transactions 120
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 21:36 | 2026-09-18 | CRMD | Dillione Janet | Dir | M - OptEx | — | +48.9K | 117.8K | +71% | — |
| 2026-09-01 20:20 | 2026-08-29 | CRMD | Blum Susan | CFO | F - Tax | $8.30 | -8,424 | 124.3K | -6% | -$69.9K | |
| 2026-09-01 20:18 | 2026-08-29 | CRMD | Hurlburt Elizabeth | COO | F - Tax | $8.30 | -8,076 | 270.5K | -3% | -$67.0K | |
| 2026-09-01 20:16 | 2026-08-29 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.30 | -8,424 | 260.7K | -3% | -$69.9K | |
| 2026-02-06 | 2026-02-04 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +36.0K | 269.1K | +15% | $0 | |
| 2026-02-06 | 2026-02-04 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +77.2K | 774.7K | +11% | $0 | |
| 2026-02-06 | 2026-02-04 | CRMD | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +36.0K | 278.5K | +15% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | Kaplan Myron | Dir | A - Grant | $0.00 | +30.5K | 231.5K | +15% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $7.27 | -8,803 | 233.1K | -4% | -$64.0K | |
| 2026-01-27 | 2026-01-23 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +72.8K | 241.9K | +43% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | DUNTON ALAN W | Dir | A - Grant | $0.00 | +30.5K | 70.7K | +76% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | Lefkowitz Steven W | Dir | A - Grant | $0.00 | +30.5K | 126.0K | +32% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +225.9K | 724.9K | +45% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $7.27 | -27.3K | 697.6K | -4% | -$198.5K | |
| 2026-01-27 | 2026-01-23 | CRMD | Blum Susan | CFO | F - Tax | $7.27 | -9,767 | 132.7K | -7% | -$71.0K | |
| 2026-01-27 | 2026-01-23 | CRMD | Blum Susan | CFO | A - Grant | $0.00 | +72.8K | 142.5K | +104% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | Stewart Robert A | Dir | A - Grant | $0.00 | +30.5K | 66.5K | +85% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | Dillione Janet | Dir | A - Grant | $0.00 | +30.5K | 68.9K | +79% | $0 | |
| 2026-01-27 | 2026-01-23 | CRMD | Hurlburt Elizabeth | COO | F - Tax | $7.27 | -10.8K | 242.5K | -4% | -$78.4K | |
| 2026-01-27 | 2026-01-23 | CRMD | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +93.0K | 253.3K | +58% | $0 | |
| 2026-01-27 | 2026-01-26 | CRMD | Duncan Gregory Scott | Dir | A - Grant | $0.00 | +30.5K | 68.8K | +79% | $0 | |
| 2026-01-22 | 2026-01-21 | CRMD | Dillione Janet | Dir | S - Sale | $6.88 | -10.0K | 38.5K | -21% | -$68.8K | |
| DM | 2026-01-20 | 2026-01-12+ | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $6.94 | -40.1K | 499.0K | -7% | -$278.2K |
| D | 2026-01-20 | 2026-01-16 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +29.6K | 521.7K | +6% | +$100.0K |
| 2026-01-20 | 2026-01-12 | CRMD | Hurlburt Elizabeth | COO | F - Tax | $7.15 | -5,794 | 160.3K | -3% | -$41.4K | |
| 2026-01-15 | 2026-01-08 | CRMD | Seckler Michael David | Chief Commercial Off | A - Grant | $0.00 | +133.2K | 133.2K | New | $0 | |
| D | 2026-01-14 | 2026-01-12 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $5.63 | +15.0K | 95.5K | +19% | +$84.5K |
| 2026-01-06 | 2026-01-02 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $12.16 | -11.3K | 169.1K | -6% | -$137.8K | |
| 2026-01-06 | 2026-01-02 | CRMD | Hurlburt Elizabeth | COO | F - Tax | $12.16 | -10.9K | 166.1K | -6% | -$132.5K | |
| D | 2026-01-02 | 2025-12-30 | CRMD | DUNTON ALAN W | Dir | M - OptEx | $4.03 | +20.0K | 60.2K | +50% | +$80.6K |
| D | 2026-01-02 | 2025-12-30 | CRMD | DUNTON ALAN W | Dir | S - Sale+OE | $13.00 | -20.0K | 40.2K | -33% | -$260.0K |
| D | 2025-12-19 | 2025-12-18 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $4.43 | +30.0K | 539.5K | +6% | +$132.9K |
| D | 2025-12-19 | 2025-12-18 | CRMD | Todisco Joseph | CEO, Dir | S - Sale+OE | $12.00 | -30.0K | 509.5K | -6% | -$360.0K |
| DM | 2025-12-11 | 2025-12-09 | CRMD | Dillione Janet | Dir | M - OptEx | $7.82 | +34.0K | 67.5K | +102% | +$265.9K |
| D | 2025-12-11 | 2025-12-09 | CRMD | Dillione Janet | Dir | S - Sale+OE | $12.00 | -34.0K | 48.5K | -41% | -$408.0K |
| 2025-12-10 | 2025-12-09 | CRMD | Lefkowitz Steven W | Dir | S - Sale | $11.88 | -40.0K | 80.5K | -33% | -$475.2K | |
| D | 2025-12-04 | 2025-12-02 | CRMD | Dillione Janet | Dir | S - Sale+OE | $10.00 | -46.7K | 48.5K | -49% | -$466.6K |
| DM | 2025-12-04 | 2025-12-02 | CRMD | Dillione Janet | Dir | M - OptEx | $3.96 | +46.7K | 95.1K | +96% | +$184.8K |
| DM | 2025-11-26 | 2025-11-24 | CRMD | Dillione Janet | Dir | M - OptEx | $3.64 | +26.3K | 56.5K | +87% | +$95.9K |
| D | 2025-11-26 | 2025-11-24 | CRMD | Dillione Janet | Dir | S - Sale+OE | $9.93 | -26.3K | 48.5K | -35% | -$261.6K |
| 2025-11-18 | 2025-11-14 | CRMD | Dillione Janet | Dir | S - Sale | $11.42 | -30.0K | 48.5K | -38% | -$342.6K | |
| 2025-10-27 | 2025-10-23 | CRMD | Kaplan Myron | Dir | P - Purchase | $11.02 | +25.0K | 201.0K | +14% | +$275.5K | |
| D | 2025-09-18 | 2025-09-16 | CRMD | Duncan Gregory Scott | Dir | M - OptEx | $8.32 | +13.3K | 38.3K | +53% | +$110.9K |
| D | 2025-09-16 | 2025-09-12 | CRMD | DUNTON ALAN W | Dir | M - OptEx | $3.55 | +10.0K | 50.2K | +25% | +$35.5K |
| D | 2025-09-16 | 2025-09-12 | CRMD | DUNTON ALAN W | Dir | S - Sale+OE | $13.13 | -10.0K | 40.2K | -20% | -$131.3K |
| 2025-09-12 | 2025-05-10 | CRMD | Todisco Joseph | CEO | F - Tax | $11.66 | -21.2K | 509.5K | -4% | -$247.5K | |
| D | 2025-09-12 | 2025-09-12 | CRMD | Todisco Joseph | CEO | S - Sale+OE | $13.00 | -50.0K | 509.5K | -9% | -$650.0K |
| D | 2025-09-12 | 2025-09-12 | CRMD | Todisco Joseph | CEO | M - OptEx | $3.47 | +50.0K | 559.5K | +10% | +$173.5K |
| DM | 2025-09-11 | 2025-09-09 | CRMD | Zelnick Kaufman Beth | CLO | S - Sale+OE | $13.41 | -50.0K | 180.4K | -22% | -$670.3K |
| D | 2025-09-11 | 2025-09-09 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | $3.30 | +50.0K | 230.4K | +28% | +$165.0K |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | Hurlburt Elizabeth | COO | M - OptEx | $1.45 | +54.0K | 189.9K | +40% | +$78.3K |
| DM | 2025-09-11 | 2025-09-09+ | CRMD | Hurlburt Elizabeth | COO | S - Sale+OE | $13.18 | -54.0K | 177.0K | -23% | -$711.8K |
| A | 2025-09-08 | 2025-08-29 | CRMD | Hurlburt Elizabeth | COO | F - Tax | $14.83 | -8,424 | 177.0K | -5% | -$124.9K |
| A | 2025-09-08 | 2025-08-29 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $14.83 | -8,880 | 180.4K | -5% | -$131.7K |
| 2025-09-03 | 2025-08-29 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +69.7K | 189.3K | +58% | $0 | |
| 2025-09-03 | 2025-08-29 | CRMD | Blum Susan | CFO | A - Grant | $0.00 | +69.7K | 69.7K | New | $0 | |
| 2025-09-03 | 2025-08-29 | CRMD | Hurlburt Elizabeth | COO | A - Grant | $0.00 | +69.7K | 185.4K | +60% | $0 | |
| D | 2025-04-03 | 2025-04-02 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $4.03 | +20.0K | 120.5K | +20% | +$80.6K |
| D | 2025-04-02 | 2025-04-01 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +59.2K | 530.7K | +13% | +$200.0K |
| 2025-01-22 | 2025-01-17 | CRMD | Lefkowitz Steven W | Dir | A - Grant | $0.00 | +25.0K | 100.5K | +33% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | Kaplan Myron | Dir | A - Grant | $0.00 | +25.0K | 176.0K | +17% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +187.5K | 495.5K | +61% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $12.17 | -24.0K | 471.6K | -5% | -$291.8K | |
| 2025-01-22 | 2025-01-17 | CRMD | Duncan Gregory Scott | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | Dillione Janet | Dir | A - Grant | $0.00 | +25.0K | 78.5K | +47% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | DUNTON ALAN W | Dir | A - Grant | $0.00 | +25.0K | 40.2K | +164% | $0 | |
| 2025-01-22 | 2025-01-17 | CRMD | Stewart Robert A | Dir | A - Grant | $0.00 | +25.0K | 36.0K | +227% | $0 | |
| 2025-01-14 | 2025-01-10 | CRMD | Mistry Erin | EVP, Chief Commercial Off | F - Tax | $11.19 | -5,689 | 101.0K | -5% | -$63.7K | |
| 2025-01-14 | 2025-01-10 | CRMD | Hurlburt Elizabeth | EVP | F - Tax | $11.19 | -5,790 | 115.7K | -5% | -$64.8K | |
| 2025-01-14 | 2025-01-10 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $11.19 | -17.8K | 308.0K | -5% | -$199.5K | |
| 2025-01-14 | 2025-01-10 | CRMD | David Matthew T | CFO | F - Tax | $11.19 | -6,515 | 95.3K | -6% | -$72.9K | |
| 2025-01-06 | 2025-01-02 | CRMD | Hurlburt Elizabeth | EVP | F - Tax | $8.22 | -11.4K | 121.5K | -9% | -$93.5K | |
| 2025-01-06 | 2025-01-02 | CRMD | Hurlburt Elizabeth | EVP | A - Grant | $0.00 | +87.5K | 132.9K | +193% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.22 | -11.8K | 119.6K | -9% | -$97.4K | |
| 2025-01-06 | 2025-01-02 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +87.5K | 131.5K | +199% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | Mistry Erin | EVP, Chief Commercial Off | A - Grant | $0.00 | +62.5K | 114.5K | +120% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | Mistry Erin | EVP, Chief Commercial Off | F - Tax | $8.22 | -7,830 | 106.7K | -7% | -$64.4K | |
| 2025-01-06 | 2025-01-02 | CRMD | David Matthew T | CFO | A - Grant | $0.00 | +62.5K | 110.4K | +130% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | David Matthew T | CFO | F - Tax | $8.22 | -8,648 | 101.8K | -8% | -$71.1K | |
| A | 2024-12-18 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.77 | -6,044 | 44.0K | -12% | -$53.0K |
| D | 2024-12-16 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | M - OptEx | — | +12.5K | 62.5K | +25% | — |
| D | 2024-12-16 | 2024-12-12 | CRMD | Zelnick Kaufman Beth | CLO | F - Tax | $8.77 | -6,044 | 56.5K | -10% | -$53.0K |
| 2024-12-13 | 2024-10-31 | CRMD | Mistry Erin | EVP, Chief Commercial Off | P - Purchase | $9.99 | +1,500 | 52.0K | +3% | +$15.0K | |
| D | 2024-11-18 | 2024-11-14 | CRMD | Hurlburt Elizabeth | EVP | S - Sale+OE | $11.18 | -140.0K | 45.4K | -76% | -$1.57M |
| DM | 2024-11-18 | 2024-11-14 | CRMD | Hurlburt Elizabeth | EVP | M - OptEx | $4.48 | +140.0K | 45.4K | New | +$627.7K |
| 2024-05-13 | 2024-05-10 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $5.17 | -27.0K | 325.9K | -8% | -$139.5K | |
| 2024-03-14 | 2024-03-13 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $3.74 | +13.6K | 352.8K | +4% | +$50.7K | |
| D | 2024-01-17 | 2024-01-12 | CRMD | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | F - Tax | $3.47 | -4,603 | 53.4K | -8% | -$16.0K |
| D | 2024-01-17 | 2024-01-12 | CRMD | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | A - Grant | $0.00 | +50.0K | 58.0K | +625% | $0 |
| D | 2024-01-17 | 2024-01-12 | CRMD | David Matthew T | CFO | F - Tax | $3.47 | -5,216 | 47.9K | -10% | -$18.1K |
| D | 2024-01-17 | 2024-01-12 | CRMD | David Matthew T | CFO | A - Grant | $0.00 | +50.0K | 53.1K | +1,587% | $0 |
| D | 2024-01-17 | 2024-01-12 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +133.3K | 353.1K | +61% | $0 |
| D | 2024-01-17 | 2024-01-12 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $3.47 | -13.8K | 339.3K | -4% | -$47.8K |
| D | 2024-01-17 | 2024-01-12 | CRMD | Mistry Erin | Chief Commercial Off | F - Tax | $3.47 | -4,389 | 50.5K | -8% | -$15.2K |
| D | 2024-01-17 | 2024-01-12 | CRMD | Mistry Erin | Chief Commercial Off | A - Grant | $0.00 | +50.0K | 54.9K | +1,020% | $0 |
| M | 2023-12-18 | 2023-12-14+ | CRMD | DUNTON ALAN W | Dir | P - Purchase | $3.38 | +6,000 | 15.2K | +65% | +$20.2K |
| D | 2023-12-14 | 2023-12-12 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| 2023-11-21 | 2023-11-17 | CRMD | Mistry Erin | Chief Commercial Off | P - Purchase | $4.00 | +1,000 | 4,900 | +26% | +$4,000 | |
| D | 2023-11-17 | 2023-11-16 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $2.25 | +15.0K | 75.5K | +25% | +$33.8K |
| 2023-09-08 | 2023-09-08 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $3.71 | +10.0K | 219.7K | +5% | +$37.1K |
Purchase Sale Sale after option exercise All abbreviations